Miguel Islas‐Ohlmayer
Miguel Islas‐Ohlmayer publishes mostly in Pathology and Forensic Medicine, Oncology and Genetics, on topics such as Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and CAR-T cell therapy research.
- World rank
- #2,126,359 of 7,710,434 ranked researchers
- Rank in United States
- #640,843 of 1,627,098
- Works
- 25
- Citations
- 1.4k
- Citations per work
- 57.2
What does Miguel Islas‐Ohlmayer research?
Miguel Islas‐Ohlmayer's work is mostly in Medicine (65%), Immunology and Microbiology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1665.3%
- Medicine1665.3%
- Everything else625.4%
- Life Sciences29.3%
- 1Pathology and Forensic Medicine19% of their works
- 2Oncology17% of their works
- 3Genetics12% of their works
- 4Pulmonary and Respiratory Medicine9% of their works
- 5Immunology9% of their works
- 6Hematology8% of their works
Research topics
Which keywords describe Miguel Islas‐Ohlmayer's research?
The keywords of their largest research topics: Rituximab, Lymphoma, Classification, Molecular Profiling, Chronic Lymphocytic Leukemia, Genomic Aberrations, CAR T Cells and Chimeric Antigen Receptor.
- Natural Killer Cells
- Prognostic Scoring System
- Kaposi's Sarcoma
- Targeted Therapy
- EGFR Mutations
- Chimeric Antigen Receptor
- Genomic Aberrations
- Molecular Profiling
- Lymphoma
- Rituximab
- Classification
- Chronic Lymphocytic Leukemia
- CAR T Cells
- Bone Marrow Niche
- Hematopoietic Stem Cells
- Epstein-Barr Virus
- Primary CNS Lymphoma
- NK Cell Recognition
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Rituximab232 topics
- Lymphoma192 topics
- Classification141 topic
- Molecular Profiling141 topic
- Chronic Lymphocytic Leukemia91 topic
- Genomic Aberrations91 topic
- CAR T Cells51 topic
- Chimeric Antigen Receptor51 topic
- Bone Marrow Niche41 topic
- EGFR Mutations41 topic
- Hematopoietic Stem Cells41 topic
- Targeted Therapy41 topic
- Epstein-Barr Virus31 topic
- Kaposi's Sarcoma31 topic
- Primary CNS Lymphoma31 topic
- Prognostic Scoring System31 topic
- NK Cell Recognition21 topic
- Natural Killer Cells21 topic
Where does Miguel Islas‐Ohlmayer work?
Miguel Islas‐Ohlmayer's main affiliation in the publication record is Texas Oncology, United States.
How many publications and citations does Miguel Islas‐Ohlmayer have?
OpenAlex counts 25 works and 1,429 citations for Miguel Islas‐Ohlmayer, an h-index of 10, ranking #2,126,359 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Miguel Islas‐Ohlmayer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.